chr1-68126260-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 6P and 1B. PS1_ModeratePM2PP5_ModerateBP4
The NM_024911.7(WLS):c.1592T>C(p.Ile531Thr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Consequence
NM_024911.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WLS | NM_024911.7 | c.1592T>C | p.Ile531Thr | missense_variant | 12/12 | ENST00000262348.9 | NP_079187.3 | |
GNG12-AS1 | NR_040077.1 | n.1074+5019A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WLS | ENST00000262348.9 | c.1592T>C | p.Ile531Thr | missense_variant | 12/12 | 1 | NM_024911.7 | ENSP00000262348 | P1 | |
GNG12-AS1 | ENST00000420587.5 | n.1059+5019A>G | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Zaki syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 05, 2021 | - - |
WLS syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | research | Gleeson Lab, University of California San Diego - Department of Neuroscience | Apr 21, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.